Back to search
FDAFDA · Food and drugs·Recall number D-1194-2022

Anastrozole/Testosterone Cypionate/Propionate 1mg/160mg/40mg/mL, 10 mL-vial, Room Temperature, Tailor Made Compounding

Published July 20, 2022 · Recall initiated: March 7, 2022

Summary

FDA records drug Class II recall D-1194-2022, published July 20, 2022 and initiated March 7, 2022. Recalling firm: TMC Acquisition LLC dba Tailor Made Compounding; Status: Ongoing; Reported quantity: 39; Lot: Batch #: 10182113A1, Exp 4/16/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
TMC Acquisition LLC dba Tailor Made Compounding
Distributor
Nationwide USA and Puerto Rico
Lot
Batch #: 10182113A1, Exp 4/16/2022.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Anastrozole/Testosterone Cypionate/Propionate 1mg/160mg/40mg/mL, 10 mL-vial, Room Temperature, Tailor Made Compounding recalled?

Yes. FDA published recall D-1194-2022 on July 20, 2022. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter